Role of RNA degradation in germline stem cell to oocyte transition
Role of RNA degradation in germline stem cell to oocyte transition
批准号:
10541733
负责人:
Prashanth Rangan
金额:
$23.66万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2024-07-31
中文摘要
摘要
英文摘要
Abstract
The germ line generates gametes that link generations by passing genetic information from parent to offspring.
During oogenesis, the egg receives critical mRNAs from the mother, called maternal mRNAs, that help launch
the next generation; any mistakes in this process could be detrimental to the offspring. However, it is not
known if specific mRNAs are selected for deposition, or what, if any, guardians ensure that the right mRNAs
are deposited. We have identified Drosophila twister (tst), the homologue of human SKI2VL, as one of the
guardians of maternal inheritance. tst encodes an ATP-dependent RNA helicase that is part of the conserved
Super Killer (Ski) complex, which funnels mRNA targets from mRNA surveillance pathways to the degradation
machinery. We find that tst mutants are viable but females are sterile. Our data suggests that Tst promotes the
degradation of mRNAs that are expressed and required in the undifferentiated cells such as germline stem
cells (GSCs). We find that this Tst-mediated degradation happens during differentiation before oocytes are
specified. Failure to degrade the GSC mRNAs in the differentiated stages results in loss of accumulation
maternal mRNAs in the oocyte resulting in oocyte death. We find that Tst-regulated mRNAs contain
polypyrimidine tracts (PTs) in the coding sequence (CDS) that can be bound by protein a PT binding protein,
Half pint (Hfp), which we find also coregulates a subset of Tst-regulated mRNAs. We hypothesized that Hfp
binding in the CDS can block translation by setting up barrier to ribosome movement on the coding sequence
(CDS). In support of this hypothesis, we find that a key protein that monitors ribosome stalling on the CDS and
can activate the No-Go decay (NGD) surveillance pathway, Pelota, also co-regulates both tst and hfp targets.
Our central hypothesis is that the Ski complex detects a subset mRNAs are expressed and function in the
GSCs and excludes these mRNAs from becoming part of the maternal inheritance by monitoring for stalled
ribosomes. The objective of our proposal is to uncover how Tst and the NGD pathway regulates maternal
mRNA inheritance via ribosome stalling. We will address this hypothesis with two specific aims: 1) Define the
role of Twister, a component of RNA degradation promoting Super Killer complex, in regulating oogenesis. 2)
Ascertain the role of No-Go decay pathway in controlling the selective elimination of mRNAs during oogenesis.
The outcomes of our proposed studies are expected to improve scientific knowledge by revealing the extent,
mechanism, and functional consequences of Tst and NGD mediated surveillance of the oocyte transcriptome.
As loss of the tst human homolog, SKIV2L, results in trichohepatoenteric syndrome (THES) that has no known
treatment. These findings will have a positive impact by providing insight into the etiology of diseases such as
THES. Further, these studies may reveal potential therapeutic targets for many diseases arising from
dysregulated RNA catabolism, including some spinal motor neuropathies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of RNA degradation in germline stem cell to oocyte transition
-
批准号:10671491
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2020
-
负责人:Prashanth Rangan
-
依托单位:
Role of RNA degradation in germline stem cell to oocyte transition
-
批准号:10456267
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2020
-
负责人:Prashanth Rangan
-
依托单位:
Role of RNA degradation in germline stem cell to oocyte transition
-
批准号:10223382
-
项目类别:
-
资助金额:$9.27万
-
财政年份:2020
-
负责人:Prashanth Rangan
-
依托单位:
Role of RNA degradation in germline stem cell to oocyte transition
-
批准号:10057764
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2020
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:10471420
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:10256640
-
项目类别:
-
资助金额:$6.48万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:10543021
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:9320849
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:8762629
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:8898856
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
Regulation of stem cell differentiation during Drosophila oogenesis
-
批准号:9816939
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2014
-
负责人:Prashanth Rangan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: